One hallmark characteristic of osteosarcoma is the upregulation of MYC, which occurs in nearly 41% of cases and is linked to an elevated risk of metastasis and reduced survival rates in patients with this disease [8]. This evidence concerns the gene MYC and osteosarcoma.